Asia-Pacific Flow Cytometry Market is Expected to Grow at a CAGR of 10.6% in the Forecast Period of 2022 to 2029

Asia-Pacific Flow Cytometry Market is growing with factors such as the increased prevalence of chronic diseases, emerging demand for cytometry instruments, increasing demand for flow cytometry in drug discovery, and growth in stem cell research and acquisition of DNA technologies.

However, the higher cost of flow cytometry instruments may obstruct the market's growth in the given forecast period.

Asia-Pacific Flow Cytometry Market Scenario                         

According to Data Bridge Market Research, the market in the Asia-Pacific region has the highest market share. The market leader is Thermo Fisher Scientific, Inc., which accounts for an estimated market share of approximately 22.11%. The company has gained outstanding sales through providing cytometry instruments to all the countries and rapid product approvals.

For instance,

  • In December 2020, Thermo Fisher Scientific Inc. acquired Phitonex, Inc., a private company that develops and commercializes high-resolution biology applications to accelerate research and development in cell therapy, immuno-oncology, and immunology research. This acquisition will expand flow cytometry and imaging multiplexing in protein and cell analysis research

Asia-Pacific Flow Cytometry MarketTrends Impacting the Market

Now the question is, which other regions is Thermo Fisher Scientific, Inc., BD, Agilent Technologies, Inc. are targeting? Data Bridge Market Research has estimated a large growth in the China flow cytometry market. The market leaders target Japan and India to be their next revenue pockets for 2022.

The Asia-Pacific flow cytometry market is becoming more competitive with companies such as Thermo Fisher Scientific, Inc., BD, Agilent Technologies, Inc., as they are the market leaders. The data bridge market research new reports highlight the major growth factors and opportunities in the Asia-Pacific market.

For more analysis on the Asia-Pacific flow cytometry market, request a briefing with our analysts:

Asia-Pacific Flow Cytometry Market Developments

  • In July 2021, BD introduced a new online portal, an e-commerce site for online purchasing that Reimagined Digital Marketplace for Flow Cytometry by 24/7 order tracking for purchasing resources. This helps in expanding the research and clinical innovation market
  • In March 2021, Agilent Technologies Ltd. acquired Resolution Biosciences (U.S), a leader in oncology solutions. This acquisition helped the company in expanding oncology diagnostics by accelerating research, solving complex analytical challenges, and improving patients therapies

Scope of the Asia-Pacific Flow Cytometry Market

The Asia-Pacific flow cytometry market is segmented based on Japan, China, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, and the Rest of Asia-Pacific. All country-based analysis of the Asia-Pacific flow cytometry market is further analyzed based on further segmentation.

The Asia-Pacific flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.

  • On the basis of product, the Asia-Pacific flow cytometry market is segmented into reagents and consumables, flow cytometry instruments, software, accessories, and services. On the basis of technology, the Asia-Pacific flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry. On the basis of application, the Asia-Pacific flow cytometry market is segmented into research applications, clinical applications, and industrial applications. On the basis of end user, the Asia-Pacific flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others. On the basis of distribution channel, the Asia-Pacific flow cytometry market is segmented into direct tenders and retail sales.

To know more about the study

Key Pointers Covered in Asia-Pacific Flow Cytometry Market Industry Trends and Forecast to 2029

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Sysmex Asia Pacific Pte Ltd
  • Agilent Technologies, Inc.
  • BD
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
  • Luminex Corporation
  • Sony Biotechnology Inc.
  • Apogee Flow Asia Ltd.
  • Cytek Biosciences
  • bioMérieux SA
  • Merck KGaA
  • Elabscience Biotechnology Inc.
  • Miltenyi Biotec
  •  Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Q2 Solutions
  • CellKraft Biotech Pvt. Ltd.
  • Sartorius AG
  • NeoGenomics Laboratories
  • Bay bioscience Co., Ltd.
  • Cell Signaling Technology, Inc.
  • CytoBuoy b.v.
  • ORFLO Technologies
  • BioLegend, Inc.
  • II-VI Incorporated

Above are the key players covered in the report, to know about more an exhaustive list of flow cytometry market companies', contact us

Research Methodology: Asia-Pacific Flow Cytometry Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturer, Geneticists, Healthcare Industry, Scientists, Research Laboratories
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others

Related Reports

Browse in Healthcare Category Related Reports@